On Tuesday, June 30, 2026, an unusual name stole the spotlight in Cairo: El-Karnak for Pharmaceuticals (ELKA) surged 10.8% to EGP 1.33. The move came in an already strong market, with 41 stocks up out of 44, giving ELKA’s rally a significance beyond a one-off speculative spike: traders were clearly rotating into names that combine defensive demand, domestic exposure and room for rerating.
At the same time, the EGX 30 index rose 1.33% to 50,488 points, underscoring a firm session for the Egyptian stock exchange today. Macro mattered. Brent crude eased to $73.12 a barrel, down 2.8% over the week, while USD/EGP stood at 49.539, up just 0.09% on the day. For Egypt, that mix is meaningful: softer oil reduces pressure on the energy import bill and imported inflation, while a relatively steady pound helps local equity valuations avoid another abrupt currency-driven reset.
Key figures
- ELKA +10.8% at EGP 1.33
- EGX 30 +1.33% at 50,488
- 41 advancers / 2 decliners / 1 unchanged
- USD/EGP 49.539 (+0.09%)
- Brent $73.12 (-2.8% week-on-week)